Where is the role of the genetic investigations in ALS?;Quelle est la place de l'enquête génétique?

Revue Neurologique

Volumn 162, Issue HS2, 2006, Pages

  Vandenberghe, N ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

ALS; Familial; Genetics; SOD1; Sporadic

Indexed keywords

APOLIPOPROTEIN E4; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450; SURVIVAL MOTOR NEURON PROTEIN;

AGEISM; AMYOTROPHIC LATERAL SCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; FAMILIAL DISEASE; GENE; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUNTINGTON CHOREA; ONSET AGE; PHENOTYPE; SCANDINAVIA; SUPEROXIDE DISMUTASE 1 GENE; X CHROMOSOMAL INHERITANCE; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; GENETIC SCREENING; GENETICS;

AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSIS, DIFFERENTIAL; GENETIC SCREENING; HUMANS;

EID: 33749679566     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. AL-CHALABENAYAT ZI AE, BAKKER MC et al. (1996). Association of apolipoprotein 4 allele with bulbar-onset motor neuron disease. Lancet, 347:159-160.
2. AL-CHALABI A, ANDERSEN PM, CHIOZA B et al. (1998). Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet, 7: 2045-2050.
3. AL-CHALABI A, ANDERSEN PM, NILSSON P et al. (1999). Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet, 8: 157-164.
4. ANDERSEN PM. (2001). Genetics of sporadic ALS. ALS and other motor neuron disorders, (suppl 1): S37-S41.
5. CAMU W, KHORIS J, MOULARD B et al. (1999). Genetics of familial ALS and consequences for diagnosis. J Neurol Sci, 165: S21-S26.
6. CORCIA P, MAYEUX-PORTAS V, KHORIS J et al. (2002). Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol, 52: 857-858.
7. CUDKOWICZ ME, MC KENNA-YASEK D, SAPP PE et al. (1997). Epidemiology of mutations in superoxyde dismutase in amyotrophic lateral sclerosis. Ann Neurol, 41: 210-221.
8. FANOS JH, GELINAS DF, MILLER RG. (2004). You have shown me my end": attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet, 129A: 248-253.
9. FIGLEWICZ DA, KRIZUS A, MARTINOLI MG et al. (1994). Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet, 3: 1757-1761.
10. FLOWERS JM, POWELL JF, LEIGH PN, ANDERSEN P, SHAW CE. (2001). Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann Neurol, 49: 643-649.
11. GAUDETTE M, HIRANO M, SIDDIQUE T. (2000). Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. ALS and other motor neuron disorders, 1: 83-89.
12. HAND CK, ROULEAU GA. (2002). Familial amyotrophic lateral sclerosis. Muscle & Nerve, 25: 135-159.
13. HAYWARD C, Colville S, SWINGLER RJ, BROCK DJH. (1999). Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology, 52: 1899-1901.
14. JACKSON M, MORRISON KE, AL-CHALABI A, BAKKER M, LEIGH PN. (1996). Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann Neurol, 39: 796-800.
15. JAFARI-SCHLUEP HF, KHORIS J, MAYEUX-PORTAS V et al. (2004). Les anomalies du gène superoxyde dismutase 1 dans la sclérose latérale amyotrophique familiale : corrélations phénotype/génotype et implications pratiques. L'expérience française et revue de la littérature. Rev Neurol (Paris), 160: 44-50.
16. JONES CT, BROCK DJ, CHANCELLOR AM, WARLOW CP, SWINGLER RJ. (1993). Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. Lancet, 342: 1050-1051.
17. JUNEJA T, PERICAK-VANCE MA, LAING NG, DAVE S, SIDDIQUE T. (1997). Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology, 48: 55-57.
18. KUNST CB. (2004). Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet, 75: 933-947.
19. LACOMBLEZ L, DOPPLER V, BEUCLER I et al. (2002). APOE : a potential marker of disease progression in ALS. Neurology, 58: 1112-1114.
20. LIN CL, BRISTOL LA, JIN L et al. (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron, 20: 589-602.
21. MOULARD B, SALACHAS F, CHASSANDE B et al. (1998). Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol, 43: 640-644.
22. MUNCH C, SEDLMEIER R, Meyer T et al. (2004). Point mutations of the p150 subunit of dynactin (DCT1) gene in ALS. Neurology, 63: 724-726.
23. OLKOWSKI ZL. (1998). Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport, 9: 239-242.
24. ORREL RW, FIGLEWICZ DA. (2001). Clinical implications of the genetics of ALS and other motor neuron diseases. Neurology, 57: 9-17.
25. Robberecht W. (2000). Genetic markers of ALS. ALS and other motor neuron disorders, (suppl 2): S57-S59.
26. ROSEN DR, SIDDIQUE T, PATTERSON D, et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 62: 59-62.
27. SHAW PJ. (2001). Genetic inroads in familial ALS. Nature Genetics, 29: 103-104.
28. SIDDIQUE T, PERICAK-VANCE MA, Caliendo J et al. (1998). Lack of association between apolipoprotein E genotype and amyotrophic lateral sclerosis. Neurogenetics, 1: 213-216.
29. SIDDONS MA, PICKERING-BROWN SM, MANN DM, OWEN F, COOPER PN. (1996). Debrisoquine hydroxylase gene polymorphism frequencies in patienst with amyotrophic lateral sclerosis. Neurosci Lett, 208: 65-68.
30. TOMKINS J, USHER P, SLADE JY, et al. (1998). Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport, 9: 3967-3970.
31. VIELHABER S, KUNZ D, WINKLER K et al. (2000). Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain, 123: 1339-1348.
32. YANG Y, HENTATI A, DENG HX et al. (2001). The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nature Genetics, 29: 160-165.